Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the ...

Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the ...

13-year-old Mikhael Azman and his parents Azman Ahmad Bakri and Farahiah Ariffin, with Prader-Willi Syndrome Association of Malaysia president Azhar Talib (right). (Bernama pic) No parent is ever ...

Q1 2025 Earnings Call Transcript May 12, 2025 Relmada Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0 ...

Harvey is blind, autistic, has septo-optic dysplasia, and is one of the 2,000 people in the UK with Prader-Willi syndrome, a genetic disorder. A recognised symptom of his Prader-Willi syndrome is ...

Harvey, 22, has a rare genetic condition called Prader-Willi syndrome, which means he's always hungry. As a consequence of his uncontrollable hunger, he is now battling life-threatening obesity.

Positive initial Phase 2 proof-of-concept data for NDV-01 at AUA 2025 showing a 90% overall response rate at any time in non-muscle invasive bladder cancer (US prevalence 600K patients) The Phase 2 st ...

Its lead candidate, Diazoxide Choline Controlled-Release (DCCR), is an oral tablet that treats Prader-Willi Syndrome (PWS).

Katie Price has shared a concerning update over her son Harvey’s weight issues and worries he’s now at risk of suffering a ...

Prader-Willi syndrome is a rare genetic neurodevelopmental disorder caused by an abnormality in the gene expression on chromosome 15, estimated to occur in one in every 15,000 live births.